Casdin Capital »

Adlai Nortye Ltd Sponsored shares owned by Casdin Capital

Quarter-by-quarter ownership of Adlai Nortye Ltd Sponsored (ANL) shares owned by Casdin Capital from 13F filings

Historical chart of Casdin Capital investment in Adlai Nortye Ltd Sponsored

Tip: Access up to 7 years of quarterly data

All positions including Adlai Nortye Ltd Sponsored held by Casdin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adlai Nortye Ltd Sponsored by Casdin Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.7M 539k 6.92

More positions owned by Casdin Capital

Revolution Medicines (RVMD)
Genedx Holdings Corp Com Cl A (WGS)
Relay Therapeutics (RLAY)
Biolife Solutions Com New (BLFS)
D Fluidigm Corp Del (LAB)
Illumina (ILMN)
Structure Therapeutics Sponsored Ads (GPCR)
10x Genomics Cl A Com (TXG)
Denali Therapeutics (DNLI)
Beam Therapeutics (BEAM)
Guardant Health (GH)
Neurogene (NGNE)
Alnylam Pharmaceuticals (ALNY)
Maze Therapeatics (MAZE)
Scholar Rock Hldg Corp (SRRK)

View all positions for Casdin Capital

Top funds holding Adlai Nortye Ltd Sponsored

VR Adviser
Cormorant Asset Management
Squadron Capital Management
Balyasny Asset Management
Millennium Management
Casdin Capital
Woodline Partners
UBS Group
Ameriprise Financial
ADAR1 Capital Management
Toroso Investments
Cantor Fitzgerald, L. P.
TD Asset Management
Ikarian Capital
Persistent Asset Partners

View all funds holding Adlai Nortye Ltd Sponsored